Corvus Pharmaceuticals, Inc. Insider Trading for June 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Corvus Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Corvus Pharmaceuticals, Inc. for June 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 27 2016 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Buy | P | 12.99 | 900 | 11,691 | 5,379,349 | 5.4 M to 5.4 M (+0.02 %) |
Jun 27 2016 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Buy | P | 12.92 | 100 | 1,292 | 5,378,449 | 5.4 M to 5.4 M (0.00 %) |
Jun 27 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 12.99 | 900 | 11,691 | 5,379,349 | 5.4 M to 5.4 M (+0.02 %) |
Jun 27 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 12.92 | 100 | 1,292 | 5,378,449 | 5.4 M to 5.4 M (0.00 %) |
Jun 21 2016 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Buy | P | 12.87 | 26,083 | 335,688 | 5,378,349 | 5.4 M to 5.4 M (+0.49 %) |
Jun 21 2016 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Buy | P | 12.48 | 12,300 | 153,504 | 5,352,266 | 5.3 M to 5.4 M (+0.23 %) |
Jun 21 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 12.87 | 26,083 | 335,688 | 5,378,349 | 5.4 M to 5.4 M (+0.49 %) |
Jun 21 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 12.48 | 12,300 | 153,504 | 5,352,266 | 5.3 M to 5.4 M (+0.23 %) |
Jun 16 2016 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Buy | P | 12.04 | 5,000 | 60,200 | 5,339,966 | 5.3 M to 5.3 M (+0.09 %) |
Jun 16 2016 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Buy | P | 11.94 | 5,000 | 59,700 | 5,334,966 | 5.3 M to 5.3 M (+0.09 %) |
Jun 16 2016 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Buy | P | 12.71 | 10,000 | 127,100 | 5,329,966 | 5.3 M to 5.3 M (+0.19 %) |
Jun 16 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 12.04 | 5,000 | 60,200 | 5,339,966 | 5.3 M to 5.3 M (+0.09 %) |
Jun 16 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 11.94 | 5,000 | 59,700 | 5,334,966 | 5.3 M to 5.3 M (+0.09 %) |
Jun 16 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 12.71 | 10,000 | 127,100 | 5,329,966 | 5.3 M to 5.3 M (+0.19 %) |
Jun 13 2016 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Buy | P | 12.98 | 20,000 | 259,600 | 5,319,966 | 5.3 M to 5.3 M (+0.38 %) |
Jun 13 2016 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Buy | P | 12.95 | 30,000 | 388,500 | 5,299,966 | 5.3 M to 5.3 M (+0.57 %) |
Jun 13 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 12.98 | 20,000 | 259,600 | 5,319,966 | 5.3 M to 5.3 M (+0.38 %) |
Jun 13 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 12.95 | 30,000 | 388,500 | 5,299,966 | 5.3 M to 5.3 M (+0.57 %) |
Jun 10 2016 | CRVS | Corvus Pharmaceuti ... | Coloma Jason V | SVP, Chief Business ... | Option Exercise | A | 13.34 | 200,000 | 2,668,000 | 200,000 |